The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Surgery for Fibrocystic Breast Changes

Surgical excision of symptomatic or suspicious fibrocystic breast lesions.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Genel Cerrahi department. Book Appointment →

What is Surgery for Fibrocystic Breast Changes?

Fibrocystic breast change is the most common benign breast condition, characterized by fibrosis, cyst formation, adenosis and epithelial hyperplasia; affects 50–60% of women in reproductive age.

Most cases are managed conservatively; surgery is reserved for symptomatic, suspicious or atypical lesions identified on imaging or biopsy.

Surgical indications include atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), discordant biopsy results, painful or large palpable masses, and ductal lesions with bloody discharge.

Pathophysiology: hormonal influences (estrogen and progesterone fluctuations) cause cyst formation, stromal fibrosis and ductal/lobular epithelial hyperplasia.

Symptoms

Lumpy or nodular breast texture, often bilateral and symmetric
Cyclic or non-cyclic breast pain (mastalgia), usually worse premenstrually
Tender or painful palpable masses, frequently changing in size
Palpable cysts (smooth, mobile, sometimes fluctuant)
Nipple discharge: clear, milky, green or bloody (bloody requires urgent evaluation)
Localized firmness or thickening, particularly in upper outer quadrants
Anxiety related to the suspicion of breast cancer
Worsening symptoms with menstrual cycle, caffeine, or hormonal therapy

Risk Factors

Reproductive-age woman (peak 30–50 years)
Family history of fibrocystic disease or atypical hyperplasia
Hormonal therapy: oral contraceptives, hormone replacement therapy
Caffeine consumption (controversial association)
Obesity and high-fat diet
Atypical hyperplasia (ADH/ALH) increases breast cancer risk 4–5×
Lobular carcinoma in situ (LCIS) increases lifetime breast cancer risk 7–10×
Cigarette smoking (increases inflammation)
Genetic factors: BRCA1/2 mutations, Cowden syndrome, Li-Fraumeni syndrome

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New, persistent or enlarging breast lump
  • Persistent breast pain not responding to conservative management
  • Bloody or unilateral spontaneous nipple discharge
  • Skin changes (dimpling, retraction, peau d'orange)
  • Recently diagnosed atypical hyperplasia or LCIS on biopsy
  • Discordant findings between imaging and biopsy
  • Increasing cyst burden with symptoms
  • Family history of breast cancer with new symptoms

Treatment Methods

01
Diagnostic workup: clinical breast examination, bilateral diagnostic mammography (>30 years), targeted ultrasound, MRI for high-risk patients
02
Image-guided biopsy: ultrasound-guided core biopsy for solid lesions, stereotactic biopsy for microcalcifications, MRI-guided biopsy for MRI-detected lesions
03
Pathological assessment: discordant biopsy results, ADH, ALH, LCIS, papillary lesions or atypia generally require surgical excision; concordant fibrocystic change with no atypia can be observed
04
Conservative management: supportive bra, decrease caffeine consumption, evening primrose oil, vitamin E (controversial), NSAIDs for pain
05
Hormonal therapy for severe mastalgia: tamoxifen 10 mg/day or danazol 200–400 mg/day for 3–6 months in severe cases (limited use due to side effects)
06
Cyst aspiration: ultrasound-guided needle aspiration of symptomatic simple cysts; bloody fluid or recurrence requires excisional biopsy
07
Surgical excision indications: ADH (mandatory excision after core biopsy due to 10–25% upgrade rate), ALH/LCIS (selective excision based on imaging-pathology concordance), papillary lesions (radial scar), discordant biopsy
08
Excisional biopsy technique: lumpectomy with margin assessment, hookwire localization for non-palpable lesions, specimen radiography for microcalcifications
09
Vacuum-assisted excision (VAE): minimally invasive alternative for selected ADH/papillary lesions; lower morbidity, similar accuracy
10
Anesthesia: local anesthesia for outpatient procedures, general anesthesia for larger or deeper lesions
11
Reconstructive considerations: oncoplastic techniques to preserve breast contour, particularly for larger excisions; tissue rearrangement, mammoplasty
12
Postoperative care: ambulatory surgery in most cases, drain placement rare, wound check at 1 week, full recovery in 2–4 weeks
13
Follow-up imaging: postoperative mammography 6 months later (baseline), then annual mammography
14
Risk reduction in atypical hyperplasia: tamoxifen 20 mg/day for 5 years (40–50% breast cancer risk reduction in ADH/ALH); aromatase inhibitors postmenopausal alternative
15
High-risk surveillance: annual MRI and mammography (alternating every 6 months) in patients with LCIS or atypical hyperplasia
16
Genetic counseling: BRCA testing in family history of breast/ovarian cancer or early-onset disease; consider risk-reducing strategies
17
Long-term outcomes: typical fibrocystic change benign with no increased malignant risk; ADH/ALH 4–5× increased breast cancer risk; LCIS 7–10× increased risk
18
Multidisciplinary follow-up: breast surgery, oncology, radiology, genetic counseling; patient education and shared decision-making for risk-reducing strategies

Which Department to Visit?

You can visit our Genel Cerrahi department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Genel Cerrahi Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Appendicitis

Genel Cerrahi

Appendicitis is inflammation of the appendix causing severe pain in the lower right abdomen. Early diagnosis and surgical treatment are life-saving.

Inguinal Hernia

Genel Cerrahi

Inguinal hernia is the protrusion of intestine or fat into the inguinal canal due to weakness in the abdominal wall. It can be permanently corrected with surgical treatment.

Umbilical Hernia

Genel Cerrahi

Umbilical hernia manifests as a soft swelling around the navel. While it often resolves spontaneously in infants, surgical treatment may be required in adults.

Gallstones and Cholecystectomy

Genel Cerrahi

Gallstones cause severe pain in the upper right abdomen, especially after fatty meals. They are safely treated with laparoscopic cholecystectomy.

Hemorrhoids (Piles)

Genel Cerrahi

Hemorrhoids result from swelling of the veins in the anus; they present with blood on toilet paper, itching, and pain. Various treatments are available, from lifestyle changes to surgery.

Anal Fissure

Genel Cerrahi

Anal fissure is a tear in the thin skin of the anal canal. It presents with sharp pain and bleeding and can be healed with medical or surgical treatment.

Pilonidal Sinus

Genel Cerrahi

Pilonidal sinus consists of tunnels and tracts prone to chronic infection, formed by hair becoming embedded under the skin in the tailbone area. Surgical treatment provides a permanent solution.

Thyroid Surgery

Genel Cerrahi

Thyroid surgery involves the removal of part or all of the thyroid gland for indications such as benign nodules, goiter, and thyroid cancer.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.